Mirum director awarded RSUs and stock options
Mirum Pharmaceuticals director Saira Ramasastry reported new equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Mirum Pharmaceuticals director Saira Ramasastry reported new equity awards. She received 1,980 restricted stock units and stock options for 3,772 shares of common stock with an exercise price of 101 per share. Both awards vest on the first anniversary of the grant date, or earlier if fully vested by Mirum’s 2027 annual stockholder meeting. The options expire on June 14, 2036. These are compensation-related grants rather than open-market purchases or sales.
Insider Trade Summary
Grant/Award: 5,752 shares
Grant/Award
2 txns
Insider
Ramasastry Saira
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 3,772 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 1,980 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 3,772 contracts (Direct);
Restricted Stock Units — 1,980 contracts (Direct)
Footnotes (2)
- F1. The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting.
- F2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting.
Key Figures
Restricted stock units granted: 1,980 units
Stock options granted: 3,772 options
Option exercise price: 101 per share
+3 more
6 metrics
Restricted stock units granted
1,980 units
Award to director Saira Ramasastry on June 15, 2026
Stock options granted
3,772 options
Award to director Saira Ramasastry on June 15, 2026
Option exercise price
101 per share
Stock option (right to buy) for Mirum common stock
Option expiration date
June 14, 2036
Expiration for 3,772 stock options granted
RSU underlying shares
1,980 shares
Each restricted stock unit equals one common share upon vesting
Option underlying shares
3,772 shares
Underlying Mirum common stock for granted options
Key Terms
Restricted Stock Units, Stock Option (right to buy), contingent right, vest
4 terms
Restricted Stock Units financial
"security_title: "Restricted Stock Units""
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
contingent right financial
"represents a contingent right to receive one share of the Issuer's common stock"
vest financial
"will vest on the first anniversary of the grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Mirum Pharmaceuticals (MIRM) report for Saira Ramasastry?
Mirum Pharmaceuticals reported that director Saira Ramasastry received equity compensation grants. She was awarded 1,980 restricted stock units and options for 3,772 shares of common stock, all reported as acquisitions rather than open-market purchases or sales.
How many restricted stock units did Saira Ramasastry receive from Mirum Pharmaceuticals (MIRM)?
She received 1,980 restricted stock units. Each unit represents a contingent right to receive one share of Mirum’s common stock, subject to vesting conditions tied to the first anniversary of the grant and the 2027 annual stockholder meeting.
What stock options were granted to Saira Ramasastry by Mirum Pharmaceuticals (MIRM)?
She was granted options covering 3,772 shares of Mirum common stock. These options have an exercise price of 101 per share, were awarded as compensation, and expire on June 14, 2036, subject to vesting requirements.
When do Saira Ramasastry’s Mirum Pharmaceuticals (MIRM) equity awards vest?
Both the restricted stock units and stock options vest on the first anniversary of the grant date. In any case, they will be fully vested no later than the date of Mirum’s 2027 annual stockholder meeting, according to the footnotes.
Are Saira Ramasastry’s Mirum Pharmaceuticals (MIRM) Form 4 transactions open-market trades?
No, the transactions are equity compensation awards. The Form 4 shows grants of restricted stock units and stock options coded as awards, not open-market buys or sells, so they reflect compensation rather than trading activity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates